In our third episode, KYBORA‘s CEO, Alan Vanderborght, sits down with Dr. Weiyong Sun, Chief Business Officer at Hansoh Bio, for a thought-provoking conversation on some of the most pressing issues in the pharmaceutical industry.
Together, they explore a range of topics — including how China’s rapidly advancing R&D capabilities are shaping the future of the U.S pharma market.
Listen at the links below:
